The Art and Science of Dermal Formulation Development (ePub)

Marc B. Brown, BSc (Hons), PhD, CChem FRSC, is the Chief Scientific Officer and Co-founder of MedPharm Ltd. He received his BSc (Hons) and PhD in Pharmaceutical Chemistry from Loughborough University. In 2006, after 14 years working as an academic at King's College London (KCL) and then as Director of Pharmaceutical Development at Hyal Pharmaceutical Corporation in Toronto, Canada, he took up a position as full-time and then part-time Chair of Pharmaceutics in the School of Pharmacy, University of Hertfordshire, where he remained until 2016. During this time, he was also awarded Honorary Professorial positions at the School of Pharmacy, University of Reading and the Institute of Pharmaceutical Science, King's College London. His research interests lie mainly in drug delivery to the skin, nail, and mucosal membranes and he has over 200 publications and 26 inventions describing his work. In 1999 whilst at KCL, Dr Brown co-founded MedPharm Ltd, a contract research organisation specialising in the development of topical and transdermal medicines. He acts as Chief Scientific Officer of MedPharm, which employs approximately 150 people in its GMP/GLP accredited facilities in the United Kingdom and the United States. He and MedPharm have been involved in the development of 50 topical and transdermal medicines and devices that have gained regulatory approval around the world. These include two generic topical products that were approved in the European Union based on bioequivalence testing alone. These submissions utilised MedPharm's validated in vitro and ex vivo performance testing models.

Adrian C. Williams, BSc (Hons), PhD, CChem FRSC, FAPS, FHEA, is Professor of Pharmaceutics and Research Dean (Health) at the University of Reading, UK. Dr Williams started working on transdermal and topical drug delivery for his PhD in 1987, under the supervision of Professor Brian Barry at the University of Bradford. Following his doctorate, he joined the